Arrivent Biopharma, Inc. · NASDAQ:AVBP
The Vanguard Group reported a 5.00% stake in Arrivent Biopharma, Inc. (Schedule 13G)
Event Sep 30, 2025 · Filed Oct 30, 2025
The Vanguard Group reported a 5.00% stake in Arrivent Biopharma, Inc., 2,029,531 shares, as a passive investor on Sep 30, 2025. Filed Oct 30, 2025 (Schedule 13G).
- Stake
- 5.00%
- Shares
- 2,029,531
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 5.00% | 2,029,531 |
Source
Related
- Arrivent Biopharma, Inc.
- The Vanguard Group
- Arrivent Biopharma, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Jan 30, 2026
- Schedule 13G · Vivo Opportunity, LLC · Oct 13, 2026
- Schedule 13D/A · Orbimed Advisors LLC · Oct 8, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · FMR LLC · May 6, 2026
- Schedule 13G/A · Sofinnova Venture Partners IX, L.P. ("SVP IX") · Mar 5, 2026